A4K2W5
Gene name |
STK4 |
Protein name |
Serine/threonine-protein kinase 4 |
Names |
|
Species |
Aotus nancymaae (Ma's night monkey) |
KEGG Pathway |
|
EC number |
2.7.11.1: Protein-serine/threonine kinases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
166-189 (Activation loop from InterPro)
Target domain |
30-281 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
Autoinhibited structure
Activated structure
1 structures for A4K2W5
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-A4K2W5-F1 | Predicted | AlphaFoldDB |
No variants for A4K2W5
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for A4K2W5 | |||||
No associated diseases with A4K2W5
6 regional properties for A4K2W5
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | SH3 domain | 210 - 269 | IPR001452 |
| domain | VHS domain | 7 - 143 | IPR002014 |
| conserved_site | Ubiquitin interacting motif | 171 - 190 | IPR003903 |
| domain | STAM1, SH3 domain | 213 - 267 | IPR035657 |
| domain | STAM1, non-canonical GAT domain | 301 - 377 | IPR047492 |
| domain | STAM1, VHS domain | 9 - 139 | IPR047528 |
Functions
| Description | ||
|---|---|---|
| EC Number | 2.7.11.1 | Protein-serine/threonine kinases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| metal ion binding | Binding to a metal ion. |
| protein serine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. |
| protein serine/threonine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| apoptotic process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| protein phosphorylation | The process of introducing a phosphate group on to a protein. |
| protein tetramerization | The formation of a protein tetramer, a macromolecular structure consisting of four noncovalently associated identical or nonidentical subunits. |
| signal transduction | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| METVQLRNPP | RRQLKKLDED | SLTKQPEEVF | DVLEKLGEGS | YGSVYKAIHK | ETGQIVAIKQ |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VPVESDLQEI | IKEISIMQQC | DSHHVVKYYG | SYFKNTDLWI | VMEYCGAGSV | SDIIRLRNKT |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LTEDEIATIL | QSTLKGLEYL | HFMRKIHRDI | KAGNILLNTE | GHAKLADFGV | AGQLTDTMAK |
| 190 | 200 | 210 | 220 | 230 | 240 |
| RNTVIGTPFW | MAPEVIQEIG | YNCVADIWSL | GITAIEMAEG | KPPYADIHPM | RAIFMIPTNP |
| 250 | 260 | 270 | 280 | 290 | 300 |
| PPTFRKPELW | SDNFTDFVKQ | CLVKSPEQRA | TATQLLQHPF | VKSAKGVSIL | RDLINEAMDV |
| 310 | 320 | 330 | 340 | 350 | 360 |
| KLKRQESQQR | EVDQDDEENS | EEDEMDSGTM | VRAVGDEMGT | VRVASTMTDG | ANTMIEHDDT |
| 370 | 380 | 390 | 400 | 410 | 420 |
| LPSQLGTMVI | NAEDEEEEGT | MKRRDETMQP | AKPSFLEYFE | QKEKENQINS | FGKSIPGPLQ |
| 430 | 440 | 450 | 460 | 470 | 480 |
| NSSDWKVPQD | GDYEFLKSWT | VEDLQKRLLA | LDPMMEQEIE | EIRQKYQSKR | QPILDAIEAK |
| KRRQQNF |